Imaging Flow Cytometry Illuminates New Dimensions of Amyloid Peptide-Membrane Interactions.
Sign Up to like & getrecommendations! Published in 2020 at "Biophysical journal"
DOI: 10.1016/j.bpj.2020.01.018
Abstract: Membrane interactions of amyloidogenic proteins constitute central determinants both in protein aggregation as well as in amyloid cytotoxicity. Most reported studies of amyloid peptide-membrane interactions have employed model membrane systems combined with application of spectroscopy… read more here.
Keywords: amyloid peptide; imaging flow; 106 126; flow cytometry ... See more keywords
Thymosin beta 4 attenuates PrP(106-126)-induced human brain endothelial cells dysfunction.
Sign Up to like & getrecommendations! Published in 2019 at "European journal of pharmacology"
DOI: 10.1016/j.ejphar.2019.172891
Abstract: The blood-brain barrier (BBB) is a highly selective permeability barrier that separates the circulating blood from the brain and extracellular fluid in the central nervous system (CNS). The BBB is formed by cerebral endothelial cells… read more here.
Keywords: dysfunction; prion; prp 106; 106 126 ... See more keywords
Thymosin Beta 4 Protects Hippocampal Neuronal Cells against PrP (106–126) via Neurotrophic Factor Signaling
Sign Up to like & getrecommendations! Published in 2023 at "Molecules"
DOI: 10.3390/molecules28093920
Abstract: Prion protein peptide (PrP) has demonstrated neurotoxicity in brain cells, resulting in the progression of prion diseases with spongiform degenerative, amyloidogenic, and aggregative properties. Thymosin beta 4 (Tβ4) plays a role in the nervous system… read more here.
Keywords: prp 106; hippocampal neuronal; thymosin beta; 106 126 ... See more keywords